Jeffrey M. Rybak PharmD, PhD
@Rybak_JM
Followers
584
Following
2K
Media
39
Statuses
409
Research Faculty, Dept of Pharmaceutical Sciences @StJude @StJudeResearch Infectious Diseases Pharmacist advancing the treatment of invasive fungal infections
Memphis , TN
Joined April 2019
New postdoc position is available in my lab! Looking for motivated candidates interested in joining a team seeking to advance the treatment of patients with infections caused by difficult-to-treat fungal pathogens (C. auris and Mucorales). Apply now : https://t.co/RyUmxbHPmc
2
28
61
Congratulations @LisaIDpharmD !!!
Excited to recognize the incredible contributions to clinical care, research, & trainee mentorship provided by Dr. @LisaIDPharmD, this year’s SIDP Outstanding Clinician Award, honored at today’s @IDWeekMtg Opening Plenary! 🎉
0
0
1
Great to have this opportunity to talk with @DrEmilyMcD, Nav, and Graham about all things Candida auris!
★ Just published: #Communicable podcast episode "The Nightmare Series, part 1: how to deal with Candida auris" Kicking off the series our hosts @DrEmilyMcD & Nav invite experts @Rybak_JM & Graham Snyder to elaborate on #Candidaauris
https://t.co/JsZR3Qa1M3
#IDtwitter #idxposts
0
0
7
We are starting to send out interview invitations for this position. If you are interested, be sure to submit your application soon! Come join a booming medical mycology community in Memphis. The TN Fungal Pathogens Group includes a growing list of more than mycology 10 labs!
0
0
2
Primary project: application of novel CRISPR tech to the molecular study of Mucor. Additional opportunities include projects relating to the study of C. auris and A. fumigatus. Competitive salary with full health benefits, relocation support, and career development programs.
1
0
2
Now hiring a postdoc in my lab at St. Jude! Looking for motivated candidates interested in mycology, CRISPR technologies, and advancing the treatment of patients with invasive fungal infections (C. auris, A. fumigatus, and Mucorales). Apply now: https://t.co/RyUmxbInbK
2
34
56
Congrats to Jinhong Xie on her first author publication out today in Nature Comm- showing the Aspergillus sterol methyl-transferase, Erg6, associates with lipid droplets, is essential, and when repressed reduces mortality in a murine aspergillosis model!! https://t.co/um1Cex4Vl5
0
6
20
Excited to share a recent publication in Nature Communications from our great team of investigators where we reveal a previously unknown secondary mechanism of action of the triazole antifungals against Aspergillus fumigatus mediated by Hmg1 https://t.co/Iu1ZwrwUTX
nature.com
Nature Communications - Triazole antifungals are widely used and exert their action by inhibiting ergosterol biosynthesis. Here, Rybak et al show that these drugs both inhibit ergosterol...
7
11
47
Great new paper on a new generation of agents to treat Mycobacterium infections from Greg Phelps in the Lee lab ( @antibioticchem ) just hitting print in PNAS. Check it out!
Off to a good start
0
2
7
Congrats Marx!!! That’s awesome and a very well deserved recognition!! @Marxk
Virtually attending the #40under40inCancer ceremony in Chicago. Unfortunately the daughter isn't impressed. Thank you!!!! 😆 @VBCancerCare @NCODAorg @SAAswim @AmplityHealth
0
0
2
Congrats to @AFlanneryPharmD @UK_COP for @NIAIDNews funding for a clinical trial testing vancomycin infusion strategy on kidney injury.
0
2
7
👇Is an issue! Most people with substance use disorder begin as teens and young adults. I'm proud to see Doug attacking the problem at the root! #beyondthescript
Assistant professor Doug Oyler (PharmD '10, R407) is co-PI on a study that will examine opioid prescriptions for adolescents after major dental procedures and implement intervention strategies to reduce the exposure of opioids to this population. More: https://t.co/a1Mj59grDJ
0
2
11
“We want to embrace a more holistic approach to #painmanagement — and there’s a lot of people that this approach could positively impact and increase their quality of life.” —Assistant Professor Doug Oyler #TwitteRx More on this study: https://t.co/a1Mj59grDJ
0
3
15
Assistant professor Doug Oyler (PharmD '10, R407) is co-PI on a study that will examine opioid prescriptions for adolescents after major dental procedures and implement intervention strategies to reduce the exposure of opioids to this population. More: https://t.co/a1Mj59grDJ
0
2
18
Great to see Greg Phelps presenting his thesis research analyzing the mechanism of action of Spectinomycin analogs for NTM infections #ECCMID2023 @stjudegraduate
0
3
11
New clinical breakpoints for moulds are being established by @CLSI_LabNews! Next up: isavuconazole and Aspergillus fumigatus. 🍄💊
0
34
122
Still have an open NIH-funded postdoc position in antifungal immunity #postdocjobs Please RT
1
35
32
UKCOP alumna Julia Landis (PharmD ‘13) won the @ASHPOfficial poster Best Practices Award! #ASHP22 #ukcopeffect Congrats, Dr. Landis! 🏆
1
2
22